[Ethics, politics, and rights in pharmacogenomics].
The article focuses in three aspects. Firstly, distinctions are drawn between pharmacogenetic testing and other types of genetic test, and the advantages of pharmacogenomics for individuals and society generally are discussed. Secondly, the article examines some of the ethical problems raised by research in and clinical aspects of pharmacogenomics. Thirdly and lastly, a number of risk potentially associated with this new technology are discussed.
Bellver Capella
Vicente
V
Universidad de Valencia, Valencia, España.
D002986:Clinical Trials as Topic / Q000941:ethics / Q000592:standards; D004345:Drug Industry; D030661:Genetic Privacy / Q000941:ethics; D005820:Genetic Testing / Q000941:ethics; D006291:Health Policy; D016045:Human Genome Project; D006801:Humans; D007258:Informed Consent / Q000941:ethics; D010597:Pharmacogenetics / Q000941:ethics* / Q000331:legislation & jurisprudence / Q000592:standards; D012109:Research Support as Topic; D012931:Social Environment; D012935:Social Justice; D013030:Spain
Etica, política y derechos en farmacogenómica.